62.20 -0.06 (-0.10%)
After hours: 7:50PM EDT
|Bid||62.01 x 1100|
|Ask||0.00 x 4000|
|Day's Range||61.69 - 62.50|
|52 Week Range||53.91 - 74.38|
|PE Ratio (TTM)||11.18|
|Earnings Date||Oct 25, 2018|
|Forward Dividend & Yield||3.20 (5.16%)|
|1y Target Est||66.59|
The Food and Drug Administration may fast-track the review process for e-cigarettes that include features to make the products less likely to be used by kids, Commissioner Scott Gottlieb told CNBC on Thursday. The FDA ordered five brands — Juul, British American Tobacco's Vuse, Altria's MarkTen, Imperial Brands' Blu E-cigs and Japan Tobacco's Logic — to submit plans within 60 days detailing how they will prevent teens from using their products. The Food and Drug Administration is considering fast-tracking the review process for e-cigarettes that include features that make the products less likely to be used by kids, Commissioner Scott Gottlieb told CNBC on Thursday.
Altria, like other tobacco stocks, has had a tough 2018, but it can still raise prices—a critical factor as sales volumes decline, argues Wells Fargo.
Can We Expect an Upside Potential in Altria Stock? Of the 16 analysts covering Altria Group (MO), 62.5% are recommending a “buy” as of September 17, while the remaining 37.5% are recommending a “hold.” None of the analysts are recommending a “sell.” That same day, analysts set an average price target of $66.59, which represents a return potential of 6.7% from the stock price of $62.44. Since the announcement of Altria’s second-quarter earnings on July 26, Stifel and Jefferies have both lowered their target prices.
Can We Expect an Upside Potential in Altria Stock? For the next four quarters, analysts are expecting Altria Group (MO) to post EPS of $4.17, which represents a 10.6% growth from $3.77 in the corresponding four quarters of the previous year. EPS growth could likely be driven by revenue growth, expansion of net margins, and share repurchases.
Can We Expect an Upside Potential in Altria Stock? For the next four quarters, analysts are expecting Altria Group (MO) to post revenues of $19.8 billion, which represents a 2.1% growth from $19.39 billion in the corresponding four quarters of the previous year. Altria is focusing on innovative product development and packaging, enhanced trade programs, and various marketing and promotional initiatives to drive sales.
As of September 17, Altria Group (MO) stock was trading at $62.44, which represents a 7.9% rise since the announcement of its second-quarter earnings on July 26. On September 12, Scott Gottlieb, commissioner of the FDA, announced that the accelerating trajectory of flavored e-cigarette usage among youths has reached epidemic proportions. The e-cigarette market is dominated by JUUL, which had 72% of the market share as of mid-August, according to Wells Fargo analyst Bonnie Herzog.
The FDA announces directives to curb e-cigarette usage among youngsters. Though this caused tobacco stocks to gain recently, it is yet to be seen if the upside can be sustained.
U.S. Smokeless Tobacco Company, the U.S. smokeless tobacco industry leader, announced today that the U.S. Food and Drug Administration accepted and filed for substantive scientific review a Modified Risk Tobacco Product application for its moist smokeless tobacco product Copenhagen® Snuff Fine Cut.
Health and Human Services Secretary Alex Azar said the agency supports the Food and Drug Administration's proposed e-cigarette crackdown. The FDA earlier this week threatened to pull e-cigarettes from shelves if manufacturers do not control teen use. The FDA is specifically ordering five brands — Juul, British American Tobacco's Vuse, Altria's MarkTen, Imperial Brands' Blu E-cigs and Japan Tobacco's Logic — to submit plans within 60 days detailing how they will prevent teens from using their products.
Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, smokeless products, and wine in the United States. Altria Group’s insiders have divested from 3.17k shares in the large-cap stockRead More...
The burgeoning popularity of e-cigarettes among young smokers has caused traditional cigarette industry players a great deal of trouble by eating into their market share. As regulators threatened to pull e-cigarettes from shelves if they do not address "widespread" teen use, shares of Altria Group Inc. ( MO), Philip Morris International Inc. ( PM), British American Tobacco Inc. ( BTI) and London-listed Imperial Brands, all closed up over 3%.
The FDA reveals serious enforcement actions related to the marketing and sale of e-cigarettes to minors, which may benefit tobacco players like Altria (MO).
On September 12, Scott Gottlieb, the FDA commissioner, announced that the accelerating trajectory of flavored e-cigarette usage among youths has reached an epidemic proportion. The FDA is considering a policy change that would expel e-cigarette products from the market.
Another wave of bullishness from Advanced Micro Devices (NASDAQ:AMD) likely got the S&P 500 over the hump, with a helping hand from Altria Group (NYSE:MO). The memory maker was down following a downgrade from Goldman Sachs, and the parent company of Snapchat stumbled after BTIG Research suggested the stock could lose another 50% of its value over the course of the next twelve months. The top trading prospects for today are Twitter (NYSE:TWTR), Danaher (NYSE:DHR) and Northern Trust (NASDAQ:NTRS).
NEW YORK, NY / ACCESSWIRE / September 13, 2018 / U.S. markets were mixed on Wednesday as technology shares declined, dragging the Nasdaq into the red. The Dow Jones Industrial Average climbed 0.11 percent to close at 25,998.92, while the S&P 500 Index jumped 0.04 percent to close at 2,888.92. The Nasdaq Composite Index dropped 0.23 percent to close at 7,954.23.
Cigarette makers rose sharply after the Food and Drug Administration said it is looking at steps to combat "an epidemic" of e-cigarette use by teenagers. The company and its partner Galapagos said a rheumatoid arthritis drug met its goals in a late-stage study. Energy companies and oil prices continued to rise Wednesday with the price of crude.
The FDA's announcement that teen usage of e-cigarettes has reached frightening levels has traditional tobacco companies surging Wednesday.
The FDA is considering taking a more aggressive approach toward cubing e-cigarette use, and tobacco stocks are jumping.
Sep.18 -- Alon Rosin, Oppenheimer head of institutional equity derivatives, discusses his options strategy with Bloomberg's Julie Hyman on "Bloomberg Markets: The Close."